Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALC Alcon Inc

2.19 (2.59%)
Mar 01 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,344,687
Bid Price
Ask Price
News (1)
Day High 86.79


52 Week Range


Day Low 85.14
Company Name Stock Ticker Symbol Market Type
Alcon Inc ALC NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
2.19 2.59% 86.74 20:00:00
Open Price Low Price High Price Close Price Prev Close
85.45 85.14 86.79 86.74 84.55
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,807 1,344,687 $ 86.19 $ 115,901,991 - 63.78 - 86.79
Last Trade Time Type Quantity Stock Price Currency
19:00:00 79,779 $ 86.74 USD

Alcon (ALC) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Alcon Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
43.36B 499.70M - 8.72B 335M 0.67 129.43
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alcon News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ALC Message Board. Create One! See More Posts on ALC Message Board See More Message Board Posts

Historical ALC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week80.0786.7979.7483.401,515,4536.678.33%
1 Month75.3586.7974.3079.79988,27611.3915.12%
3 Months71.7786.7971.45577.93841,06014.9720.86%
6 Months83.3686.7969.4476.16832,0953.384.05%
1 Year68.3586.7963.7875.58899,29618.3926.91%
3 Years69.8288.7855.2173.54855,38416.9224.23%
5 Years58.24588.7839.3766.491,009,15928.5048.92%

Alcon Description

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Your Recent History

Delayed Upgrade Clock